The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates

Jingjiao Zhou, Yudie Wang, Juan Zhao, Lixing Gu, Cheng‐Ta Yang, Jun Wang, Heng Zhang, Yu Tian, Tuo Hu, Dan Li, Min Wei, Bing HeEuropean 2020 · DOI

Introduction

Pregnancy is characterized by a delicate state of "immune quiescence" and significant metabolic adaptations designed to support fetal growth. During the third trimester, mothers naturally experience increased insulin resistance and shifts in lipid metabolism. This study, published in the European Journal of Clinical Microbiology & Infectious Diseases, examines whether SARS-CoV-2 infection acts as a "second hit," pushing these physiological adaptations into pathological territory and potentially affecting the neonate through vertical transmission.

Methodology

The researchers conducted an observational study of 16 pregnant women (gestational age 35–39 weeks) admitted to Renmin Hospital of Wuhan University between January and March 2020. Diagnostics included RT-PCR for SARS-CoV-2, chest CT scans, and extensive blood and urine biochemistry for both mothers and neonates. To minimize birth-related transmission risks, neonates were delivered via cesarean section. Maternal data were compared against a reference group of healthy pregnancies to isolate the impact of the viral infection.

Maternal Metabolic and Coagulation Stress

The study found that COVID-19 exacerbates pregnancy-related metabolic stress. Notably, 69% of the infected mothers exhibited significant ketonuria (++ or +++), suggesting that the infection, coupled with the energy demands of late pregnancy, forces aggressive fat mobilization. This state can lead to metabolic acidosis if not managed.

Furthermore, infected mothers showed a marked hypercoagulable state. Median D-dimer levels were 3.32 mg/L (IQR 2.18–4.21), nearly double the 1.70 mg/L observed in healthy pregnancies. Elevated Fibrinogen Degradation Product (FDP) levels further indicated a high risk for disseminated intravascular coagulation (DIC) and thrombosis, requiring clinical management with low-molecular-weight heparin.

Neonatal Impact and Evidence of Vertical Transmission

Neonates born to infected mothers showed systemic signs of stress, even when initial viral tests were negative. These infants exhibited significantly higher median leukocyte counts (15.7 × 10⁹/L) compared to healthy controls (12.3 × 10⁹/L, p < 0.01). Elevated levels of Creatine Kinase (CK) and Lactate Dehydrogenase (LDH) suggested potential cardiac or multi-organ stress during gestation.

A critical finding was the presence of high SARS-CoV-2 IgM titers (46 AU/mL) in one neonate at birth. Because IgM antibodies are too large to cross the placental barrier, their presence strongly suggests that the fetus produced them in response to an in utero infection, providing a "smoking gun" for vertical transmission.

Chest CT scan features: Panels (a)-(e) illustrate maternal lung lesions and subsequent recovery; panel (f) shows increased lung markings in an infected neonate.

Conclusion and Limitations

While the study is limited by its small sample size (16 mother-neonate pairs), it provides high-resolution evidence of the systemic impact of COVID-19 on late pregnancy. The findings highlight the need for rigorous metabolic and coagulation monitoring in infected pregnant women. Although neonatal IgM findings are compelling, the authors note that definitive confirmation of intrauterine transmission requires PCR data from cord blood, placenta, or amniotic fluid, which were not available for all cases. Future research should focus on larger cohorts to map the long-term developmental outcomes for these neonates.

Summary updated

BibTeX
@inproceedings{zhou2020metabolic,
  author = {Jingjiao Zhou and Yudie Wang and Juan Zhao and Lixing Gu and Cheng‐Ta Yang and Jun Wang and Heng Zhang and Yu Tian and Tuo Hu and Dan Li and Min Wei and Bing He},
  title = {{The metabolic and immunological characteristics of pregnant women with COVID-19 and their neonates}},
  booktitle = {European},
  year = {2020},
  doi = {10.1007/s10096-020-04033-0},
}
Figure